Stockscreener 앱 받기
35.64
0.06%
0.02
전일 마감가:
$35.62
열려 있는:
$35.62
하루 거래량:
512.30K
Relative Volume:
1.00
시가총액:
$1.15B
수익:
$780.57M
순이익/손실:
$62.87M
주가수익비율:
20.76
EPS:
1.7171
순현금흐름:
$327.58M
1주 성능:
+8.79%
1개월 성능:
+3.30%
6개월 성능:
+10.79%
1년 성능:
+33.33%
1일 변동 폭
$35.35
$36.27
1주일 범위
$33.06
$36.27
52주 변동 폭
$25.86
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
35.64 | 1.15B | 780.57M | 62.87M | 327.58M | 1.7171 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-01-10 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-05-10 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-10 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-25 | 재확인 | Needham | Buy |
| 2023-05-02 | 재개 | Jefferies | Buy |
| 2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-14 | 개시 | BWS Financial | Sell |
| 2020-05-27 | 개시 | Guggenheim | Neutral |
| 2020-02-19 | 재개 | Jefferies | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-03 | 재개 | H.C. Wainwright | Buy |
| 2019-04-12 | 재개 | Janney | Buy |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2018-02-07 | 재확인 | Needham | Buy |
| 2017-12-05 | 재확인 | Needham | Buy |
| 2017-09-11 | 개시 | H.C. Wainwright | Buy |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-09-13 | 개시 | Gabelli & Co | Buy |
| 2015-06-01 | 개시 | Jefferies | Buy |
| 2015-06-01 | 개시 | Needham | Buy |
| 2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
Is Collegium Pharmaceutical (COLL) one of the best small-cap drug manufacturers? - MSN
Aug Technicals: Does Collegium Pharmaceutical Inc offer margin of safetyGlobal Markets & Daily Chart Pattern Signals - baoquankhu1.vn
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Smith Thomas B - Moomoo
How The Collegium Pharmaceutical (COLL) Narrative Is Evolving On A Modest Target Price Shift - Yahoo Finance
Assessing Collegium Pharmaceutical (COLL) Valuation After Mixed Recent Share Price Performance - Sahm
Chipmakers Recap: What is the target price for Collegium Pharmaceutical Inc stockGDP Growth & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Sectors Review: Does Collegium Pharmaceutical Inc offer margin of safetyBreakout Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
COLL SEC FilingsCollegium Pharmaceutical Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Precision Trading with Collegium Pharmaceutical Inc. (COLL) Risk Zones - Stock Traders Daily
Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks - TradingView — Track All Markets
Collegium to Participate in Upcoming Investor Conferences - Bitget
Collegium Pharmaceutical, Inc. (COLL) stock price, news, quote and history - Yahoo Finance UK
Collegium to webcast Needham fireside chat, post 90-day replay - Stock Titan
Collegium Pharmaceutical, Inc. Files Form 8-K with SEC: Company Details, Stock Information, and Filing Data (April 2, 2026) - Minichart
How Prospective US Tariffs on Branded Drug Imports Will Impact Collegium Pharmaceutical (COLL) Investors - Sahm
Collegium Pharmaceutical, Inc. (COLL) Stock forecasts - Yahoo Finance UK
Inflation Data: What are analysts price targets for Collegium Pharmaceutical Inc2026 Momentum Check & Safe Entry Trade Reports - baoquankhu1.vn
Collegium (NASDAQ: COLL) posts strong 2025 growth and seeks backing on board, pay and auditor - Stock Titan
Collegium Pharmaceutical (NASDAQ: COLL) nominates Michael Donovan as director as John Fallon retires - Stock Titan
GE HealthCare and Collegium Pharmaceutical stocks trade down, what you need to know - MSN
Chipmakers Recap: Should I hold or sell Collegium Pharmaceutical Inc now2026 Highlights & Reliable Volume Spike Alerts - baoquankhu1.vn
COLL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Collegium Pharmaceutical (COLL) Valuation Check After Recent Share Price Pullback - Sahm
Collegium (COLL) EVP has 8,840 shares withheld for RSU tax payment - Stock Titan
Collegium Pharmaceutical (COLL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know - Yahoo Finance
Collegium Pharmaceutical (COLL) surged following record quarterly results - MSN
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo Finance
Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million - AOL.com
Collegium Pharma Executive David Dieter Sells Shares in March 2026News and Statistics - IndexBox
Collegium Pharmaceutical Acquires AZSTARYS for $650M - National Today
Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers - Insider Monkey
Aug Volume: Can Collegium Pharmaceutical Inc be the next market leaderSell Signal & AI Enhanced Trading Alerts - baoquankhu1.vn
JPMorgan Chase & Co. Acquires 139,689 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD - The Motley Fool
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD - The Motley Fool
Wedge Capital Management L L P NC Acquires New Stake in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Published on: 2026-03-30 05:44:15 - baoquankhu1.vn
Collegium Pharmaceutical Inc (NASDAQ:COLL) Presents a Compelling Value Investment Case - ChartMill
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is It Time To Reassess Collegium Pharmaceutical (COLL) After The Recent Share Price Pullback? - simplywall.st
Collegium’s AZSTARYS Deal And Insider Sale Put Focus On Valuation - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares in Collegium (COLL) - Stock Titan
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) - Yahoo Finance
Collegium Pharmaceutical, Inc. $COLL Shares Bought by Assenagon Asset Management S.A. - MarketBeat
Collegium Pharmaceutical, Inc. (COLL) to Present 9 Pain Studies at PAINWeek 2025 - MSN
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.06%
1.05%
자본화:
|
볼륨(24시간):